Skip to main content
EUPATI Open Classroom
  • About
  • Learning Catalogue
  • FAQ
  • Glossary
  • Accessibility
    High Contrast Bigger Text
  • Log in

Welcome to EUPATI Open Classroom!

EUPATI Open Classroom is the brand-new e-learning platform developed by EUPATI. 

It features a flexible and on-demand learning catalogue and allow patients, patient representatives and other stakeholders from anywhere in the world to take courses in medicines research and development.

Learn more!

How does EUPATI Open Classroom work?

Easy! You can explore the courses and navigate the website as a Guest (no account needed) or you can  become an official Learner (by registering and creating an account).

Watch the tutorial video for more details.

Questions? Find the Answers!

What is EUPATI?

EUPATI is the European Patients' Academy on Therapeutic Innovation. It's a unique training provider specialized in patient education that offers different training courses and education materials. 

EUPATI is committed to changing the face of patient engagement through patient education.


Learn more!

Skip Custom Sections
Custom Sections

What kind of courses does the platform offer?

Take a look at the Learning Catalogue Overview and explore the available courses on medicines research and development. Also find out more details about how the platform works.

Section 1 Image
Read more!

Ready to start learning?

Participants from anywhere in the world can enrol to EUPATI Open Classroom. Learners can take the courses online on-demand at their own pace and preferred order.

As a guest you can navigate and explore the platform but as register user you will have access to more functionalities and also keep track on your learning pathway.

Section 2 Image
Register!

Would you like to become a EUPATI Fellow?

Graduates of the EUPATI Patient Expert Training Programme are also known as EUPATI Fellows. The title certifies the knowledge gained and will give you the opportunity to be recognised as an expert patient. Also EUPATI Fellow is a well-known label within the patient engagement landscape.

Join the EUPATI Alumni of 200+ graduates.

Section 3 Image
Read the FAQ

EUPATI Training Portfolio

In addition to the EUPATI Open Classroom the new on-demand eLearning platform featuring courses on Medicines R&D, EUPATI offers in-person and online trainings about patient engagement and also can provide tailored trainings according to your organisation or local needs.


Section 4 Image
Learn more!
Skip Marketing Spots
Marketing Spots

EUPATI Fellow testimonial

A graduate from the EUPATI Patient Expert Training Programme shared her experience and answer some questions about how being a EUPATI fellow has help her to expand her evolvement in patient engagement activities.

Listen to the podcast!

Patient Engagement Roadmap

To help you structure your learning pathway, we strongly recommend to check the Patient Engagement Roadmap first. It gives an overview on how the courses of the EUPATI Open Classroom can be reflected and used in practical terms and according to the experience.




More details

EUPATI Platforms

EUPATI has recently launched several new online platforms including a multilingual Medicines R&D and Patient Engagement Toolbox, a ' Collaborate' area and a new website for the European Patients' Academy.

Check it now!
Skip Featured glossary entry
Featured glossary entry

Absorption

In pharmacology and pharmacokinetics, absorption is the process whereby medicines are transported or taken up from the site of administration (by mouth, inhalation, intravenous or intramuscular injection, etc.) to the blood through capillary, osmotic, solvent, or chemical action in the cells. This could be through the intestinal wall, skin, or mucous membranes.

In specific situations, such as intravenous (IV) therapy, absorption is straightforward and there is less variability, because the medicine goes directly in to the bloodstream. In the case of IV injection, the bioavailability of the compound is 100%.

Absorption is a primary focus in medicines development, as a compound must first be absorbed before any medicinal effects can take place. Moreover, the medicine™s pharmacokinetic profile can be significantly changed by factors that affect absorption.
View all entries

Patient Engagement Roadmap

The value of patient involvement in medicines research and development is increasingly recognised by all stakeholders. Unfortunately, limited formal documentation of patient involvement activities hampers the sharing of experience and learnings, preventing timely and systematic implementation. 

To overcome that challenge the content of the EUPATI Patient Expert Programme has been developed following the Patient Engagement Roadmap, a process model that provides guidance for patient involvement in the different areas of the medicines R&D process.

Research Priorities
Research Design & Planning
Research Conduct & Operations
Dissemination, Communication, Post-Approval

Research Priorities

High expertise in disease area required

Setting research priorities
- Gap analysis - Early Horizon Scanning - Matching unmet needs with research
- Defining patient-relevant added value and outcomes

Research Design & Planning

High expertise in disease area required

Protocol Synopsis
- Design - Target population

Protocol Design
- Relevant endpoints - Benefit / Risk balance - In-/Exclusion criteria
- Diagnosis procedures - Quality of life and Patient Reported Outcomes (PROs)
- Ethical issues - Data protection - Mobility issues/logistics - Adherence measures

Medium expertise in disease area required

Practical Considerations
- Contractual issues - Travel expenses - Support for family members - Mobility

Patient Information
- Content - Visual design - Readability - Language - Dissemination

Informed Consent
- Content - Visual design - Readability - Language

Fundraising for Research

Ethical Review

Research Conduct & Operations

High expertise in disease area required

Trial Steering Committee
- Protocol follow up - Improving access - Adherence

Information to Trial Participants
- Protocol amendments - New safety information

Investigators Meeting
- Trial design - Recruitment
- Challenges - Opportunities can trigger amendments

Data Safety Monitoring Committee
- Benefit/Risk
- Drop-out issues - Amendments

Medium expertise in disease area required

Study Reporting
- Summary of interim results
- Dissemination in patient community

Dissemination, Communication, Post-Approval

High expertise in disease area required

Regulatory Affairs
- MAA Evaluation - EPAR Summaries - Lay summary of results
- Package leaflets - Updated safety communication

Medium expertise in disease area required

Health Technology Assessment (HTA)
- Assessment of value - Patient-relevant outcomes - Patient priorities

Post-communication study
- Contribution to publications
- Dissemination of research results to patient community / professionals

  • About
  • Learning Catalogue
  • FAQ
  • Glossary
    • Accessibility
    High Contrast Bigger Text
    Home

    © 2021 EUPATI

    EUPATI Open Classroom is supported by the EUPATI Reload project, funded by EIT Health and managed by Bayer, University of Copenhagen and the European Patients' Forum (EPF).

    If you want more info or provide feedback about EUPATI Open Classroom platform please send an email to: info@eupati.eu

    EUPATI Twitter | EUPATI LinkedIn

    Terms & Conditions | Privacy and Cookie Policy

    You are not logged in. (Log in)
    Powered by Moodle Workplace
    Help